This COVID-19 vaccine linked to lower risk for clotting, blockages
By
Kristen Fischer
Aug 04, 2023
A study that put both COVID-19 shots to the test to see which was better for older adults found that the Moderna vaccine was superior.
This year’s new tripledemic: COVID-19, flu and RSV
By
Kristen Fischer
Jul 25, 2023
It’s going to be a pretty busy cold, flu and respiratory syncytial virus season, according to the US Centers for Disease Control and Prevention. COVID-19 is on the rise now, a year after the country...
Medicaid to cover all FDA-approved adult vaccines on Oct. 1, CMS reminds states
By
Alicia Lasek
Jun 28, 2023
The Centers for Medicare & Medicaid Services has released more information on mandatory state Medicaid and CHIP program coverage of vaccines recommended for adults.
Study confirms effectiveness of bivalent COVID booster; AHCA helps spread word
By
Alicia Lasek
Dec 22, 2022
New data and support materials are available for clinicians who want to encourage more residents and staff to get the updated COVID-19 booster shot.
CDC: More nursing homes now can obtain, provide single-dose COVID vaccines
By
Alicia Lasek
Dec 20, 2022
Nursing homes that are not already enrolled as full providers in the CDC’s COVID-19 Vaccination Program now can apply to provide shots directly to residents and staff.
As respiratory diseases spike, CDC urges clinicians to offer vaccines, antivirals
By
Alicia Lasek
Nov 08, 2022
U.S. health officials have asked clinicians to help lessen the impact of an exceptional respiratory virus season on seniors and other vulnerable Americans.
Vaccine to protect seniors from RSV ready for FDA review, drugmaker says
By
Alicia Lasek (f3)
Jun 13, 2022
A vaccine to help prevent a leading cause of pneumonia in the elderly has been found effective in late-stage clinical trials.
Providers embracing reprieve as staff vaccine deadline passes unenforced
By
Kimberly Marselas
Dec 09, 2021
Skilled nursing providers with large shares of their workforce still unvaccinated nearly a year after COVID-19 vaccines first became available are breathing sighs of relief across the country this week.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Protection declines dramatically over time for all three COVID-19 vaccines: study
By
Amy Novotney
Nov 08, 2021
As the delta variant became the dominant strain of coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among...